Autoria: GUIMARÃES, M. Z. P.; DE VECCHI, R.; VITÓRIA, G.; SOCHACKI, J. K.; PAULSEN, B. S.; LIMA, I.; SILVA, F. R. da; COSTA, R. F. M. da; CASTRO, N. G.; BRETON, L.; REHEN, S. K.

Resumo: Neural crest stem cells (NCPCs) have been shown to differentiate into various cell types and tissues during embryonic development, including sensory neurons. The few studies addressing the generation of NCPCs and peripheral sensory neurons (PSNs) from human induced pluripotent stem cells (hiPSCs), generated sensory cells without displaying robust activity. Here, we describe an efficient strategy for hiPSCs differentiation into NCPCs and functional PSNs using chemically defined media and factors to achieve efficient differentiation, confirmed by the expression of specific markers. After 10 days hiPSCs differentiated into NCPCs, cells were then maintained in neural induction medium containing defined growth factors for PSNs differentiation, followed by 10 days in neonatal human epidermal keratinocytes- (HEKn-) conditioned medium (CM). We observed a further increase in PSN markers expression and neurites length after CM treatment. The resulting neurons elicited action potentials after current injection and released substance P (SP) in response to nociceptive agents such as anandamide and resiniferatoxin. Anandamide induced substance P release via activation of TRPV1 and not CB1. Transcriptomic analysis of the PSNs revealed the main dorsal root ganglia neuronal markers and a transcriptional profile compatible with C fiber-low threshold mechanoreceptors. TRPV1 was detected by immunofluorescence and RNA-Seq in multiple experiments. In conclusion, the developed strategy generated PSNs useful for drug screening that could be applied to patient-derived hiPSCs, consisting in a powerful tool to model human diseases in vitro.

Ano de publicação: 2018

Tipo de publicação: Artigo de periódico

Unidade: Embrapa Agricultura Digital

Palavras-chave: Human induced pluripotent stem cells, Neural crest stem cells, Neurônios sensoriais, Pré-clínico, Substância P, TRPV1